Home
Mail
Search
News
Finance
Sport
Lifestyle
Celebrity
Movies
Weather
Mobile
More
Yahoo
Mail
Cryptocurrencies
News
Property
Money
Markets
Industries
Watchlists
My Portfolio
My Screeners
Singapore markets close in 1 hour 18 minutes
Straits Times Index
3,300.05
+7.12
(+0.22%)
Nikkei
38,236.07
-38.03
(-0.10%)
Hang Seng
18,564.22
+88.30
(+0.48%)
FTSE 100
8,213.49
+41.34
(+0.51%)
Bitcoin USD
64,441.91
+589.55
(+0.92%)
CMC Crypto 200
1,371.32
+58.69
(+4.47%)
ADC Therapeutics SA (ADCT)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
4.9000
+0.1700
(+3.59%)
At close: 04:00PM EDT
4.9000
0.00
(0.00%)
After hours:
05:53PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
69,558
69,558
209,908
33,917
0
Cost of revenue
2,529
2,529
3,301
1,393
0
Gross profit
67,029
67,029
206,607
32,524
0
Operating expenses
Research development
127,127
127,127
186,457
158,002
142,032
Selling general and administrative
105,888
105,888
143,494
136,242
77,231
Total operating expenses
232,080
232,080
329,594
293,878
218,679
Operating income or loss
-165,051
-165,051
-122,987
-261,354
-218,679
Interest expense
46,325
46,325
36,731
18,340
4,926
Total other income/expenses net
5,417
5,417
10,333
28,123
-23,190
Income before tax
-195,419
-195,419
-146,817
-251,505
-245,963
Income tax expense
39,106
39,106
227
-21,479
327
Income from continuing operations
-240,053
-240,053
-157,128
-230,026
-246,290
Net income
-240,053
-240,053
-157,128
-230,026
-246,290
Net income available to common shareholders
-240,053
-240,053
-157,128
-230,026
-246,290
Basic EPS
-2.18
-
-2.01
-3.00
-3.77
Diluted EPS
-2.18
-
-2.01
-3.00
-3.77
Basic average shares
81,260
-
78,153
76,748
65,410
Diluted average shares
81,260
-
78,153
76,748
65,410
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.